Polycythemia Vera Presenting as Cardiac Arrest: Novel Management Strategies

by Mark I. Davis, Brian K. Courtney, Gideon Cohen, Stephanie Poon, Mina Madan
Published 2019-01-01

Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada

by Ashlay A. Huitema, MD, FRCPC, Alexia Daoust, MSc, Kim Anderson, MD, MSc, FRCPC, Stephanie Poon, MD, MSc, FRCPC, Sean Virani, MD, MSc, MPH, FRCPC, FCCS, Michel White, MD, FRCP(C), FACC, FESC, Carlos Rojas-Fernandez, PharmD, Shelley Zieroth, MD, FCCS, FRCPC, Robert S. McKelvie, MD, PhD, FRCPC
Published 2020-09-01

Surveillance for Outcomes Selected as Atrial Fibrillation Quality Indicators in Canada: 10-Year Trends in Stroke, Major Bleeding, and Heart Failure

by Stephen B. Wilton, MD, MSc, Padma Kaul, PhD, Sunjidatul Islam, MBBS, MSc, Clare L. Atzema, MD, Jennifer Cruz, NP-Adult, MN, Kendra MacFarlane, MSc, Robert McKelvie, MD, PhD, Stephanie Poon, MD, Laurie Lambert, PhD, Kathy Rush, PhD, RN, Marc Deyell, MD, D. George Wyse, MD, PhD, Jafna L. Cox, MD, Allan Skanes, MD, Roopinder K. Sandhu, MD, MPH
Published 2021-05-01